Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Lowe

Showing results (91-100 of 372) with videos related to

Pageof 38
Sort By:
British Heart Journal|April 1, 1993
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health StudyA J Lee, G D Lowe, M Woodward, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Determinants of fibrin D-dimer in the Edinburgh Artery StudyA J Lee, G R Fowkes, G D Lowe, et al.
Lancet (London, England)|May 14, 1983
Increased plasmin activity during stanozolol administrationM Small, J T Douglas, G D Lowe, et al.
Thrombosis Research|October 15, 1986
The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitusM Small, G D Lowe, A C MacCuish, et al.
The Quarterly Journal of Medicine|December 1, 1987
Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic controlM Small, G D Lowe, A C MacCuish, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly StudyJ W Yarnell, P M Sweetnam, A Rumley, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Lifestyle factors and coagulation activation markers: the Caerphilly StudyJ W Yarnell, P M Sweetnam, A Rumley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophiliaM D McColl, A Omran, I D Walker, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 1, 1995
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemiaK R Woodburn, A Rumley, G D Lowe, et al.
Lancet (London, England)|March 17, 1984
AIDS and hepatitis BK S Froebel, G D Lowe, R Madhok, et al.
Pageof 38

Showing results (91-100 of 372) with videos related to

Sort By:
Pageof 38
British Heart Journal|April 1, 1993
Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health StudyA J Lee, G D Lowe, M Woodward, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Determinants of fibrin D-dimer in the Edinburgh Artery StudyA J Lee, G R Fowkes, G D Lowe, et al.
Lancet (London, England)|May 14, 1983
Increased plasmin activity during stanozolol administrationM Small, J T Douglas, G D Lowe, et al.
Thrombosis Research|October 15, 1986
The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitusM Small, G D Lowe, A C MacCuish, et al.
The Quarterly Journal of Medicine|December 1, 1987
Thrombin and plasmin activity in diabetes mellitus and their association with glycaemic controlM Small, G D Lowe, A C MacCuish, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 15, 2000
Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly StudyJ W Yarnell, P M Sweetnam, A Rumley, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Lifestyle factors and coagulation activation markers: the Caerphilly StudyJ W Yarnell, P M Sweetnam, A Rumley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Acute renal failure complicating high-dose intravenous immunoglobulin therapy for acquired haemophiliaM D McColl, A Omran, I D Walker, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 1, 1995
Fibrinogen and markers of fibrinolysis and endothelial damage following resolution of critical limb ischaemiaK R Woodburn, A Rumley, G D Lowe, et al.
Lancet (London, England)|March 17, 1984
AIDS and hepatitis BK S Froebel, G D Lowe, R Madhok, et al.
Pageof 38